News
Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
Pipeline operator Williams will seek to build two natural-gas supply lines to New York following talks between President Trump and Gov. Kathy Hochul. GameStop makes its first bitcoin buy. Here's why ...
18h
MedPage Today on MSNRFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor ProbeHHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...
Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...
The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...
California Healthline: Silence On E. Coli Outbreak Highlights How Trump Team’s Changes Undermine Food Safety Food ...
Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...
Despite their widely touted benefits — primarily weight loss and diabetes control, among others — GLP-1 medications have also ...
9h
The Healthy @Reader's Digest on MSNWhat Is Food Noise? Experts ExplainJaime Almandoz, MD, is triple board-certified in internal medicine, endocrinology, and obesity medicine, and has completed ...
GLP-1 drugs like Ozempic are revolutionizing diabetes care. But they’re also making users less likely to drink alcohol. That ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results